We put you first. Our understanding of your goals defines how we do business.

  • Superior responsiveness and service delivery.
  • Sophisticated, high quality advice delivered in a way that lets business people make business decisions.
  • Business network collaboration to get the deal done – beyond the legal work.
  • Flexibility and creativity in pricing and no surprises in your legal bills at closing.

We work with strategic and private equity buyers and sellers across a wide variety of industries, as well as institutions, funds and individuals who provide capital and direction.

  • Billions in M&A and financing transactions each year.
  • Negotiation of sophisticated deals opposite the largest law firms coast to coast.
  • Exceptional guidance identifying and evaluating opportunities for growth and liquidity by merger, divestiture, minority investment, joint venture, strategic alliance and licensing.
  • Experience in-house at companies like Medtronic, UnitedHealth Group, St. Jude, Polaris and General Mills.
  • Subject matter experts in all areas impacting growth transactions, including finance, cross-border, IP, antitrust, employment, benefits, real estate, environmental, FCPA, FDA and supply chain.


Our team represents over 130 clients in M&A transactions every year. In 2022 we closed over 250 transactions worth nearly $12 billion in diverse industries through a comprehensive range of transaction structures. We maintain a strong concentration in the health care and life sciences industries, representing over 150 clients on the leading edge of medical devices, diagnostics, imaging, health IT, care delivery, biologics and pharmaceuticals. We also represent a number of clients in the manufacturing, energy, food, service and technology industries.

Representative Transactions

  • Bio-Techne: Over $500 million of transactions in the last three years. Recent acquisitions include Bionostics, Protein Simple, CyVek, Novus Biologicals and Cliniqa. Also provide corporate governance support to the board of directors and company leadership and advice regarding SEC compliance, employment, benefits, litigation and other matters.
  • Carlson, Inc.: Acquisition of interest in the Carlson Wagonlit Travel (CWT) business from JPMorgan Chase & Co., giving Carlson 100% ownership of CWT.
  • Eurofins Scientific SE: Several acquisitions totaling over $800 million including recent acquisitions of QC Laboratories, Experchem Laboratories, BioDiagnostics, Boston Heart and ViraCor-IBT Laboratories.
  • Medtronic: Hundreds of growth transactions including mergers, acquisitions and divestitures; securities offerings; strategic investments; secured, unsecured, and convertible debt; acquisition options; rights of first refusal/negotiation and distribution, manufacturing/supply and IP license agreements. Recent representation includes Medtronic’s acquisition of Visualase in an all-cash merger transaction valued at $105 million.
  • MVC Capital: Represented MVC in the acquisition of the business of AccuMED Innovative Technologies, a company with significant operations located in Free Trade Zones in the Dominican Republic. The deal allowed MVC to establish a new platform for growth in the area of medical device component manufacturing.
  • Talenti Gelato & Sorbetto: Represented the Minneapolis-based gelato company founded in 2003 in its sale to Unilever. Talenti was ranked as Minnesota’s fourth fastest-growing company by the Minneapolis-St. Paul Business Journal in 2014.
  • Thomson Reuters: Acquisitions of technology businesses from several private entities.


Main Contacts

Show all Mergers & Acquisitions professionals

News & Insights


Speaking Engagements

Jump to Page

Fredrikson & Byron, P.A. stores cookies on your device to enhance site navigation, make your browsing experience as useful as possible, and analyze site usage. By accessing this website with cookies enabled in your web browser, you agree to the storing of cookies on your device. Please read our Privacy Policy and our Disclaimer.